Studying protein complexes with structural genomics

Proteins in vivo often function in complexes, and indeed, that?s how many individual structural biology efforts approach them. Not structural genomics efforts, though: For all their high-throughput methods, structural genomics pipelines typically treat proteins individually, in isolation. A linkurl:paper;http://www.pnas.org/cgi/content/abstract/0602606103v1 released May 11 in __PNAS__ could help bridge this gap. The new method, developed by linkurl:David Eisenberg;http://www.doe-mbi.ucla.edu/P

By | May 18, 2006

Proteins in vivo often function in complexes, and indeed, that?s how many individual structural biology efforts approach them. Not structural genomics efforts, though: For all their high-throughput methods, structural genomics pipelines typically treat proteins individually, in isolation. A linkurl:paper;http://www.pnas.org/cgi/content/abstract/0602606103v1 released May 11 in __PNAS__ could help bridge this gap. The new method, developed by linkurl:David Eisenberg;http://www.doe-mbi.ucla.edu/People/Eisenberg/ of the University of California, Los Angeles, and colleagues combines a series of linkurl:bioinformatics analyses;http://mysql5.mbi.ucla.edu/cgi-bin/functionator/pronav that scour a genome for clues suggesting that two genes are functionally linked (that is, that they both participate in a particular complex, pathway, or biological function), with experimental methods to validate those predictions. The group focused on two large, but poorly characterized protein families in the __Mycobacterium tuberculosis__ genome, called PE and PPE. Of 17 PE and 11 PPE proteins tested in their study, only one was soluble in __E. coli__ on its own, and that one was unfolded. But when they jointly expressed one member of each family on a polycistronic message in bacteria, the proteins formed a highly expressed, heterodimeric complex. The resulting crystal structure reveals why neither protein was soluble individually: both proteins expose an "extended apolar interface" that is only buried (and thus, stabilized) when the two proteins form a complex. This is precisely the reason why approaching proteins piecemeal is so hit or miss: many proteins simply don?t behave well in isolation. That observation dovetails nicely with a lesson I learned a few months ago at linkurl:Keystone;http://www.the-scientist.com/blog/display/23090/ -- that structural genomics approaches, especially of eukaryotic proteins, have high failure rates. Given the experience of Eisenberg et al. with the PE and PPE families, I wonder if perhaps this new approach might not go a long way toward improving the odds.

Comments

Avatar of: Asmodeus

Asmodeus

Posts: 1

May 23, 2006

would this mean that there is a case for companies in the protein analysis and protein-chip field as valid investments ?\n\nSuch as (german only, sorry):\n\nAlfred Wieder AG ? MIG Beteiligung Protagen AG

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech